
The global AI in Medical Imaging and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for AI in Medical Imaging and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI in Medical Imaging and Diagnostics.
Report Scope
The AI in Medical Imaging and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI in Medical Imaging and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI in Medical Imaging and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Siemens Healthineers AG
GE Healthcare
IBM Watson Health
BenevolentAI
Philips Healthcare
AliveCor Inc.
Zebra Medical Vision, Inc.
Riverain Technologies
Vuno, Inc.
Aidoc
Neural Analytics
Imagen Technologies
Digital Diagnostics, Inc.
Google (Subsidiary of Alphabet, Inc.)
Heartflow
Digital Diagnostics (Formerly Known as Idx)
Segment by Type
Software Tools/Platform
Services
Segment by Application
In Vitro Diagnostics
In Vivo Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI in Medical Imaging and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software Tools/Platform
1.2.3 Services
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 In Vitro Diagnostics
1.3.3 In Vivo Diagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Perspective (2019-2030)
2.2 AI in Medical Imaging and Diagnostics Growth Trends by Region
2.2.1 Global AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI in Medical Imaging and Diagnostics Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 AI in Medical Imaging and Diagnostics Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Dynamics
2.3.1 AI in Medical Imaging and Diagnostics Industry Trends
2.3.2 AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Drivers
2.3.3 AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Challenges
2.3.4 AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI in Medical Imaging and Diagnostics Players by Revenue
3.1.1 Global Top AI in Medical Imaging and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global AI in Medical Imaging and Diagnostics Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI in Medical Imaging and Diagnostics Revenue
3.4 Global AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI in Medical Imaging and Diagnostics Revenue in 2023
3.5 AI in Medical Imaging and Diagnostics Key Players Head office and Area Served
3.6 Key Players AI in Medical Imaging and Diagnostics Product Solution and Service
3.7 Date of Enter into AI in Medical Imaging and Diagnostics Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 AI in Medical Imaging and Diagnostics Breakdown Data by Type
4.1 Global AI in Medical Imaging and Diagnostics Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global AI in Medical Imaging and Diagnostics Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 AI in Medical Imaging and Diagnostics Breakdown Data by Application
5.1 Global AI in Medical Imaging and Diagnostics Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global AI in Medical Imaging and Diagnostics Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size (2019-2030)
6.2 North America AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa AI in Medical Imaging and Diagnostics Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens Healthineers AG
11.1.1 Siemens Healthineers AG Company Detail
11.1.2 Siemens Healthineers AG Business Overview
11.1.3 Siemens Healthineers AG AI in Medical Imaging and Diagnostics Introduction
11.1.4 Siemens Healthineers AG Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.1.5 Siemens Healthineers AG Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare AI in Medical Imaging and Diagnostics Introduction
11.2.4 GE Healthcare Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.2.5 GE Healthcare Recent Development
11.3 IBM Watson Health
11.3.1 IBM Watson Health Company Detail
11.3.2 IBM Watson Health Business Overview
11.3.3 IBM Watson Health AI in Medical Imaging and Diagnostics Introduction
11.3.4 IBM Watson Health Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.3.5 IBM Watson Health Recent Development
11.4 BenevolentAI
11.4.1 BenevolentAI Company Detail
11.4.2 BenevolentAI Business Overview
11.4.3 BenevolentAI AI in Medical Imaging and Diagnostics Introduction
11.4.4 BenevolentAI Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.4.5 BenevolentAI Recent Development
11.5 Philips Healthcare
11.5.1 Philips Healthcare Company Detail
11.5.2 Philips Healthcare Business Overview
11.5.3 Philips Healthcare AI in Medical Imaging and Diagnostics Introduction
11.5.4 Philips Healthcare Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.5.5 Philips Healthcare Recent Development
11.6 AliveCor Inc.
11.6.1 AliveCor Inc. Company Detail
11.6.2 AliveCor Inc. Business Overview
11.6.3 AliveCor Inc. AI in Medical Imaging and Diagnostics Introduction
11.6.4 AliveCor Inc. Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.6.5 AliveCor Inc. Recent Development
11.7 Zebra Medical Vision, Inc.
11.7.1 Zebra Medical Vision, Inc. Company Detail
11.7.2 Zebra Medical Vision, Inc. Business Overview
11.7.3 Zebra Medical Vision, Inc. AI in Medical Imaging and Diagnostics Introduction
11.7.4 Zebra Medical Vision, Inc. Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.7.5 Zebra Medical Vision, Inc. Recent Development
11.8 Riverain Technologies
11.8.1 Riverain Technologies Company Detail
11.8.2 Riverain Technologies Business Overview
11.8.3 Riverain Technologies AI in Medical Imaging and Diagnostics Introduction
11.8.4 Riverain Technologies Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.8.5 Riverain Technologies Recent Development
11.9 Vuno, Inc.
11.9.1 Vuno, Inc. Company Detail
11.9.2 Vuno, Inc. Business Overview
11.9.3 Vuno, Inc. AI in Medical Imaging and Diagnostics Introduction
11.9.4 Vuno, Inc. Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.9.5 Vuno, Inc. Recent Development
11.10 Aidoc
11.10.1 Aidoc Company Detail
11.10.2 Aidoc Business Overview
11.10.3 Aidoc AI in Medical Imaging and Diagnostics Introduction
11.10.4 Aidoc Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.10.5 Aidoc Recent Development
11.11 Neural Analytics
11.11.1 Neural Analytics Company Detail
11.11.2 Neural Analytics Business Overview
11.11.3 Neural Analytics AI in Medical Imaging and Diagnostics Introduction
11.11.4 Neural Analytics Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.11.5 Neural Analytics Recent Development
11.12 Imagen Technologies
11.12.1 Imagen Technologies Company Detail
11.12.2 Imagen Technologies Business Overview
11.12.3 Imagen Technologies AI in Medical Imaging and Diagnostics Introduction
11.12.4 Imagen Technologies Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.12.5 Imagen Technologies Recent Development
11.13 Digital Diagnostics, Inc.
11.13.1 Digital Diagnostics, Inc. Company Detail
11.13.2 Digital Diagnostics, Inc. Business Overview
11.13.3 Digital Diagnostics, Inc. AI in Medical Imaging and Diagnostics Introduction
11.13.4 Digital Diagnostics, Inc. Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.13.5 Digital Diagnostics, Inc. Recent Development
11.14 Google (Subsidiary of Alphabet, Inc.)
11.14.1 Google (Subsidiary of Alphabet, Inc.) Company Detail
11.14.2 Google (Subsidiary of Alphabet, Inc.) Business Overview
11.14.3 Google (Subsidiary of Alphabet, Inc.) AI in Medical Imaging and Diagnostics Introduction
11.14.4 Google (Subsidiary of Alphabet, Inc.) Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.14.5 Google (Subsidiary of Alphabet, Inc.) Recent Development
11.15 Heartflow
11.15.1 Heartflow Company Detail
11.15.2 Heartflow Business Overview
11.15.3 Heartflow AI in Medical Imaging and Diagnostics Introduction
11.15.4 Heartflow Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.15.5 Heartflow Recent Development
11.16 Digital Diagnostics (Formerly Known as Idx)
11.16.1 Digital Diagnostics (Formerly Known as Idx) Company Detail
11.16.2 Digital Diagnostics (Formerly Known as Idx) Business Overview
11.16.3 Digital Diagnostics (Formerly Known as Idx) AI in Medical Imaging and Diagnostics Introduction
11.16.4 Digital Diagnostics (Formerly Known as Idx) Revenue in AI in Medical Imaging and Diagnostics Business (2019-2024)
11.16.5 Digital Diagnostics (Formerly Known as Idx) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Siemens Healthineers AG
GE Healthcare
IBM Watson Health
BenevolentAI
Philips Healthcare
AliveCor Inc.
Zebra Medical Vision, Inc.
Riverain Technologies
Vuno, Inc.
Aidoc
Neural Analytics
Imagen Technologies
Digital Diagnostics, Inc.
Google (Subsidiary of Alphabet, Inc.)
Heartflow
Digital Diagnostics (Formerly Known as Idx)
Ìý
Ìý
*If Applicable.
